Alliancebernstein L.P. Provention Bio, Inc. Transaction History

Alliancebernstein L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $3.85 Million - $13.9 Million	574,627 Added 627.32%	666,227 $16.1 Million
Q3 2022 Nov 15, 2022	BUY	$3.43 - $5.62 $16,121 - $26,414	4,700 Added 5.41%	91,600 $412,000
Q1 2022 May 13, 2022	BUY	$3.4 - $7.88 $1,020 - $2,364	300 Added 0.35%	86,900 $636,000
Q2 2021 Jul 30, 2021	BUY	$6.71 - $11.04 $291,214 - $479,135	43,400 Added 100.46%	86,600 $730,000
Q1 2021 May 06, 2021	SELL	$10.12 - $19.45 $94,116 - $180,885	-9,300 Reduced 17.71%	43,200 $453,000
Q3 2020 Nov 12, 2020	SELL	$10.34 - $15.2 $19,646 - $28,880	-1,900 Reduced 3.49%	52,500 $674,000
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $424,864 - $924,800	54,400 New	54,400 $768,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.